Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 1;30(3):845-877.
doi: 10.1212/CON.0000000000001435.

Neuro-oncologic Emergencies

Carolina B Maciel, Katharina M Busl
Review

Neuro-oncologic Emergencies

Carolina B Maciel et al. Continuum (Minneap Minn). .

Abstract

Objective: Neuro-oncologic emergencies have become more frequent as cancer remains one of the leading causes of death in the United States, second only to heart disease. This article highlights key aspects of epidemiology, diagnosis, and management of acute neurologic complications in primary central nervous system malignancies and systemic cancer, following three thematic classifications: (1) complications that are anatomically or intrinsically tumor-related, (2) complications that are tumor-mediated, and (3) complications that are treatment-related.

Latest developments: The main driver of mortality in patients with brain metastasis is systemic disease progression; however, intracranial hypertension, treatment-resistant seizures, and overall decline due to increased intracranial burden of disease are the main factors underlying neurologic-related deaths. Advances in the understanding of tumor-specific characteristics can better inform risk stratification of neurologic complications. Following standardized grading and management algorithms for neurotoxic syndromes related to newer immunologic therapies is paramount to achieving favorable outcomes.

Essential points: Neuro-oncologic emergencies span the boundaries of subspecialties in neurology and require a broad understanding of neuroimmunology, neuronal hyperexcitability, CSF flow dynamics, intracranial compliance, and neuroanatomy.

PubMed Disclaimer

References

    1. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018;391(10125):1023–1075. doi:10.1016/S0140-6736(17)33326-3 - DOI
    1. Ostrom QT, Price M, Neff C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019. Neuro Oncol 2022;24(Suppl 5):v1–v95. doi:10.1093/neuonc/noac202 - DOI
    1. Mukherjee D, Zaidi HA, Kosztowski T, et al. Disparities in access to neuro-oncologic care in the United States. Arch Surg 2010;145(3):247–53. doi:10.1001/archsurg.2009.288 - DOI
    1. Mandel JJ, Youssef M, Nam J, et al. Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol 2019;142(2):365–374. doi:10.1007/s11060-019-03108-z - DOI
    1. Michaelson NM, Watsula A, Bakare-Okpala A, et al. Disparities in neuro-oncology. Curr Neurol Neurosci Rep 2023;23(12):815–825. doi:10.1007/s11910-023-01314-x - DOI

LinkOut - more resources